Cannabis Market by Product Type (Flowers, Concentrates, Edibles, Topicals & Tinctures), Compound (THC-Dominant, CBD-Dominant, and Balanced THC & CBD), Application (Medical and Recreational), and Region (North America, South America, Europe and RoW) - Global Forecast to 2027
Cannabis Market by Product Type (Flowers, Concentrates, Edibles, Topicals & Tinctures), Compound (THC-Dominant, CBD-Dominant, and Balanced THC & CBD), Application (Medical and Recreational), and Region (North America, South America, Europe and RoW) - Global Forecast to 2027
Abstract
The global cannabis market size is estimated to be valued at USD 27.7 billion in 2022 and is projected to reach USD 82.3 billion by 2027, recording a CAGR of 24.3% in terms of value. The cannabis market is driven by the rise in the use of cannabis for recreational and medical use. Moreover, there has been an increased legalization of cannabis in the US in states like Virginia in 2021 and Rhode Island in 2022 and in other countries like in Malta in 2021, and Thailand in 2018.
The cannabis industry is growing rapidly and witnessing a double-digit growth rate globally. There are several major companies operating in the cannabis segment that dominate their respective markets. Thus, companies are competing to gain a significant market share. The leading players in the cannabis market and medical industry are undertaking inorganic growth strategies, such as expansions & investments and acquisitions—to increase their profits and market shares. For instance, in May 2020, Aurora Cannabis Inc. completed the acquisition of Reliva LLC (US), a leader in the sales of hemp-derived CBD products in the US. The acquisition took place for USD 40 million of Aurora's common shares. This acquisition would enable the company to strengthen its position in the market and increase profitability.
“By application, the recreational segment is projected to grow at the highest CAGR during the forecast period.”
Recreational cannabis demand is increasing continuously driven by Gen Z consumers. A small but encouraging portion of cannabis products are being sold to women due to a shift in public opinion, and this percentage is predicted to increase over time. Moreover, legalization has have led to a trend toward cannabis-related tourism, with locations producing novel holiday items to entice clients and increasing travel bookings to cannabis-legal destinations.
“By compound, the THC-dominant segment is estimated to account for the largest share.”
THC strain is used for both medical and recreational applications, which increases its demand among manufacturers as well as consumers. Growing Together Research Inc., an Indiana-based biotechnology business, has created a new technique for genetically regulating the expression of Delta-9-THC in cannabis, including the capacity to boost cannabinoid levels in marijuana varieties grown for recreational or medical purposes. Moreover, other forms of THC, such as delta-8-THC, are gaining popularity in addition to the conventional version.
“The Europe region is projected to grow at the highest CAGR during the forecast period”
The market in Europe is majorly driven by the awareness of medical benefits of cannabis in the region coupled with the healthcare system present in several European countries that covers the health expenditure of most patients in these regions. As the legalization of cannabis in European countries is at a nascent stage, this creates a considerable opportunity for companies to establish themselves in the region. Since the beginning of 2019, the European cannabis market has witnessed multiple mergers and acquisitions involving companies focused on medical cannabis. Like in the starting of 2021 medical cannabis firm GW Pharmaceutical was acquired by Jazz Pharmaceutical for USD 6.15 Billion.
Break-up of Primaries:
By Value Chain Side: Demand Side-59%, Supply Side-41%
By Designation: CXOs-31%, Managers – 24%, D-Level- 30%, and Executives- 45%
By Region: Europe - 25%, Asia Pacific – 15%, North America - 45%, RoW – 5%, South America-10%
Leading players profiled in this report:
•Canopy Growth Corporation (Canada)
•Aurora Cannabis Inc. (Canada)
•Medmen Enterprise Inc. (US)
•Tilray Inc. (US)
•Unrivaled Brand Inc. (US)
•VIVO Cannabis Inc. (Canada)
•The Cronos Group (Canada)
•Medical Marijuana Inc. (US)
•Stenocare (Denmark)
•Trulieve (US)
•Organigrams Holding Inc. (Canada)
•Cresco Labs (US)
•Maricann Group Inc. (Canada)
•Indiva (Canada)
•Hexo Corp. (Canada)
•Ecofibre Limited (Australia)
•Curaleaf Holdings Inc. (US)
•Harvest Health and Recreation (US)
•Green Thumb Industries (US)
•TerrAscend (Canada)
Research Coverage:
The report segments the cannabis market on the basis on product type, application, compound, and region. In terms of insights, this report has focused on various levels of analyses—the competitive landscape, end-use analysis, and company profiles, which together comprise and discuss views on the emerging & high-growth segments of the global cannabis, high-growth regions, countries, government initiatives, drivers, restraints, opportunities, and challenges.
Reasons to buy this report:
•To get a comprehensive overview of the cannabis market
•To gain wide-ranging information about the top players in this industry, their product portfolios, and key strategies adopted by them
•To gain insights about the major countries/regions in which the cannabis market is flourishing
Content
Table of Contents
1INTRODUCTION36
1.1STUDY OBJECTIVES36
1.2MARKET DEFINITION36
1.3STUDY SCOPE37
FIGURE 1MARKET SEGMENTATION37
1.3.1INCLUSIONS AND EXCLUSIONS37
1.3.2REGIONS COVERED38
1.3.3YEARS CONSIDERED38
1.4CURRENCY CONSIDERED39
TABLE 1USD EXCHANGE RATES CONSIDERED, 2017–202139
1.5STAKEHOLDERS39
1.6SUMMARY OF CHANGES40
2RESEARCH METHODOLOGY41
2.1RESEARCH DATA41
FIGURE 2CANNABIS MARKET: RESEARCH DESIGN41
2.1.1SECONDARY DATA42
2.1.1.1Key data from secondary sources42
2.1.2PRIMARY DATA43
2.1.2.1Key data from primary sources43
2.1.2.2Key industry insights44
2.1.2.3Breakdown of primary interviews44
FIGURE 3BREAKDOWN OF PRIMARY INTERVIEWS BY COMPANY TYPE, DESIGNATION, AND REGION44
2.2MARKET SIZE ESTIMATION45
FIGURE 4CANNABIS MARKET SIZE ESTIMATION, BY TYPE (SUPPLY-SIDE)46
FIGURE 5CANNABIS MARKET SIZE ESTIMATION (DEMAND-SIDE)46
2.2.1MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH47
FIGURE 6CANNABIS MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH47
2.2.2MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH47
FIGURE 7CANNABIS MARKET SIZE ESTIMATION: TOP-DOWN APPROACH48
2.3DATA TRIANGULATION49
FIGURE 8DATA TRIANGULATION49
2.4ASSUMPTIONS50
2.5RESEARCH LIMITATIONS AND ASSOCIATED RISKS51
3EXECUTIVE SUMMARY52
TABLE 2CANNABIS MARKET SHARE SNAPSHOT, 2022 VS. 2027 (USD MILLION)52
FIGURE 9CANNABIS MARKET SIZE, BY APPLICATION, 2022 VS. 2027 (USD MILLION)53
FIGURE 10CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2022 VS. 2027 (USD MILLION)53
FIGURE 11CANNABIS MARKET SIZE, BY COMPOUND, 2022 VS. 2027 (USD MILLION)54
FIGURE 12CANNABIS MARKET SHARE AND GROWTH RATE (VALUE), BY REGION, 202154
4PREMIUM INSIGHTS56
4.1ATTRACTIVE OPPORTUNITIES IN CANNABIS MARKET56
FIGURE 13GROWING MEDICINAL APPLICATIONS AND INCREASING LEGALIZATION OF CANNABIS CREATE OPPORTUNITIES IN MARKET56
4.2CANNABIS MARKET: MAJOR REGIONAL SUBMARKETS56
FIGURE 14NORTH AMERICA ACCOUNTED FOR LARGEST SHARE GLOBALLY IN 202156
4.3NORTH AMERICA: CANNABIS MARKET, BY COMPOUND AND COUNTRY57
FIGURE 15IN 2021, US ACCOUNTED FOR LARGEST SHARE IN NORTH AMERICA57
4.4CANNABIS MARKET, BY APPLICATION57
FIGURE 16RECREATIONAL SEGMENT TO DOMINATE CANNABIS MARKET DURING FORECAST PERIOD57
4.5CANNABIS MARKET, BY COMPOUND58
FIGURE 17TETRAHYDROCANNABINOL (THC)-DOMINANT COMPOUND TO DOMINATE CANNABIS MARKET DURING FORECAST PERIOD58
4.6CANNABIS MARKET, BY PRODUCT TYPE AND REGION58
FIGURE 18NORTH AMERICA TO DOMINATE CANNABIS MARKET DURING FORECAST PERIOD58
5MARKET OVERVIEW59
5.1INTRODUCTION59
5.2MACROECONOMIC INDICATORS59
5.2.1INCREASE IN AGING POPULATION59
FIGURE 19INCREASING POPULATION OF INDIVIDUALS AGED 60 AND ABOVE (2021–2021)60
5.2.2ECONOMIC DOWNTURN60
FIGURE 20UNEMPLOYMENT AS A PERCENTAGE OF TOTAL LABOR FORCE (2010–2021)61
5.3MARKET DYNAMICS62
FIGURE 21CANNABIS MARKET DYNAMICS62
5.3.1DRIVERS62
5.3.1.1Rising cannabis demand for medicinal applications62
5.3.1.2Legalization of cannabis and rise in social acceptance63
FIGURE 22GLOBAL CANNABIS REGULATORY OVERVIEW INDICATING LEGALITY OF MEDICAL RECREATIONAL CANNABIS, 202064
5.3.1.3Growth in R&D activities and technological advancements to be precursors for cannabis business64
5.3.1.4Rising global cannabis sales helping online retailers expand66
5.3.2RESTRAINTS66
5.3.2.1Complex regulatory structure for use of cannabis66
5.3.2.2Problems associated with high dose of cannabis consumption67
5.3.2.3Stigmatization of cannabis market67
5.3.2.4Profit margins of manufacturers shrinks as cannabis prices fall68
FIGURE 23AVERAGE SELLING PRICES OF CANNABIS, 2019–202268
5.3.3OPPORTUNITIES69
5.3.3.1Emergence of cannabis legalization in Asia Pacific69
5.3.3.2Edibles, led by gummies and chocolates, to present additional growth opportunities for cannabis business70
5.3.3.3Inorganic growth strategies adopted by US cannabis companies70
5.3.4CHALLENGES71
5.3.4.1Intensive water consumption and inability to maintain consistency during cannabis cultivation71
5.3.4.2Cannabis-producing businesses face financing difficulties in US71
5.3.4.3Advertising and marketing restrictions in US72
5.3.4.4Supply chain challenges associated with cannabis in US72
6INDUSTRY TRENDS73
6.1INTRODUCTION73
6.2VALUE CHAIN73
6.2.1RESEARCH AND PRODUCT DEVELOPMENT73
6.2.2RAW MATERIAL SOURCING73
6.2.3PRODUCTION74
6.2.4PACKAGING, STORAGE, AND DISTRIBUTION74
6.2.5RETAIL74
FIGURE 24CANNABIS MARKET: VALUE CHAIN75
6.3SUPPLY CHAIN ANALYSIS75
FIGURE 25CANNABIS MARKET: SUPPLY CHAIN75
6.4TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES76
6.4.1REVENUE SHIFT AND NEW REVENUE POCKETS IN CANNABIS MARKET76
FIGURE 26REVENUE SHIFT IMPACTING CANNABIS MARKET76
6.5MARKET MAPPING AND ECOSYSTEM OF CANNABIS MARKET76
6.5.1DEMAND-SIDE76
6.5.2SUPPLY-SIDE77
FIGURE 27CANNABIS MARKET ECOSYSTEM MAP77
6.5.3ECOSYSTEM MAP77
TABLE 3CANNABIS MARKET: ECOSYSTEM77
6.6TECHNOLOGY ANALYSIS79
6.6.1LED GLOW LIGHT79
6.6.2NANOENCAPSULATION79
6.6.3ARTIFICIAL INTELLIGENCE AND BLOCKCHAIN80
FIGURE 28PROCESSES TRACKED BY USING SEED-TO-SALE TRACKER81
6.6.4CROP STEERING81
6.6.5VERTICAL FARMING82
6.6.6INNOVATIVE HARDWARE TECH DEVICES82
6.6.7IOT AUTOMATION83
6.6.8GENETIC ENGINEERING83
6.7PRICING ANALYSIS84
6.7.1SELLING PRICES CHARGED BY KEY PLAYERS IN TERMS OF PRODUCT TYPE84
FIGURE 29SELLING PRICES OF KEY PLAYERS FOR CANNABIS PRODUCT TYPE84
TABLE 4SELLING PRICE OF KEY PLAYERS FOR PRODUCT TYPE85
FIGURE 30AVERAGE SELLING PRICE IN KEY REGIONS, BY PRODUCT TYPE, 2018–2021 (USD/KG)85
TABLE 5FLOWER: AVERAGE SELLING PRICE, BY REGION, 2018–2021 (USD/KG)86
TABLE 6CONCENTRATES: AVERAGE SELLING PRICE, BY REGION, 2018–2021 (USD/KG)86
TABLE 7EDIBLES: AVERAGE SELLING PRICE, BY REGION, 2018–2021 (USD/KG)86
TABLE 8TOPICALS & TINCTURES: AVERAGE SELLING PRICE, BY REGION, 2018–2021 (USD/KG)86
TABLE 9OTHER PRODUCT TYPES: AVERAGE SELLING PRICE, BY REGION, 2018–2021 (USD/KG)87
6.8CANNABIS MARKET: PATENT ANALYSIS87
FIGURE 31NUMBER OF PATENTS GRANTED FOR CANNABIS MARKET, 2011–202187
FIGURE 32TOP PATENT APPLICANTS FOR CANNABIS MARKET, 2019–202288
FIGURE 33REGIONAL ANALYSIS OF PATENTS GRANTED FOR CANNABIS MARKET, 2019–202288
6.8.1LIST OF MAJOR PATENTS88
TABLE 10LIST OF A FEW PATENTS IN CANNABIS MARKET, 2019–202288
6.9TRADE ANALYSIS: CANNABIS MARKET90
6.9.1EXPORT SCENARIO OF HEMP90
FIGURE 34HEMP EXPORT, BY KEY COUNTRY, 2017–2021 (USD THOUSAND)90
TABLE 11EXPORT DATA OF HEMP FOR KEY COUNTRIES, 2021 (VALUE AND VOLUME)90
6.9.2IMPORT SCENARIO OF HEMP91
FIGURE 35HEMP IMPORT, BY KEY COUNTRY, 2017–2021 (USD THOUSAND)91
TABLE 12IMPORT DATA OF HEMP FOR KEY COUNTRIES, 2021 (VALUE AND VOLUME)91
6.10CASE STUDIES: CANNABIS MARKET92
6.10.1FILTER420: ATTEMPTS TO BUILD BRAND VALUE92
6.10.2ONYX AGRONOMICS: PRECISION CANNABIS FACILITY92
6.11KEY CONFERENCES AND EVENTS, 2022–202393
TABLE 13KEY CONFERENCES AND EVENTS IN CANNABIS MARKET93
6.12TARIFF AND REGULATORY LANDSCAPE94
6.12.1REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS94
TABLE 14NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS94
TABLE 15EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS95
TABLE 16SOUTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS95
TABLE 17REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS96
6.12.2REGULATORY FRAMEWORK96
FIGURE 36GLOBAL CANNABIS REGULATORY OVERVIEW INDICATING LEGALITY OF MEDICAL RECREATIONAL CANNABIS, 202296
6.12.2.1North America97
FIGURE 37US CANNABIS REGULATORY OVERVIEW, 202297
6.12.2.1.1US97
6.12.2.1.1.1Alaska-legalization measure approved in November 201497
6.12.2.1.1.2Arizona-legalization measure approved in November 202097
6.12.2.1.1.3California-legalization measure approved in November 201697
6.12.2.1.1.4Colorado-legalization measure approved in November 201298
6.12.2.1.1.5Connecticut-legalization measure approved in June 202198
6.12.2.1.1.6Guam-legalization measure approved in April 201998
6.12.2.1.1.7Illinois-legalization measure approved in May 201998
6.12.2.1.1.8Maine-legalization measure approved in November 201698
6.12.2.1.1.9Massachusetts-legalization measure approved in November 201698
6.12.2.1.1.10Michigan-legalization measure approved in November 201898
6.12.2.1.1.11Montana-legalization measure approved in January 202199
6.12.2.1.1.12New Jersey-legalization measure approved in November 202099
6.12.2.1.1.13New Mexico- legalization measure approved in April 202199
6.12.2.1.1.14New York-legalization measure approved in March 202199
6.12.2.1.1.15Oregon-legalization measure approved in November 201499
6.12.2.1.1.16Rhode Island-legalization measure approved in May 2022100
6.12.2.1.1.17Vermont-legalization measure approved in January 2018100
6.12.2.1.1.18Virginia-legalization measure approved in April 2021100
6.12.2.1.1.19Washington-legalization measure approved in November 2012100
6.12.2.1.2Canada100
6.12.2.2Europe101
6.12.2.2.1German-legalization measure approved in 2017101
6.12.2.2.2Italy-legalization measure approved in 2014101
6.12.2.2.3Denmark-legalization measure approved in January 2018101
6.12.2.2.4Malta-legalization measure approved in January 2018101
6.12.2.2.5Netherlands-legalization measure approved in January 2013102
6.12.2.2.6France-legalization measure approved in March 2022102
6.12.2.2.7Switzerland102
6.12.2.2.8UK103
6.12.2.2.9Belgium103
6.12.2.2.10Poland103
6.12.2.2.11Czech Republic103
6.12.2.2.12Spain103
6.12.2.2.13Austria103
6.12.2.2.14Norway103
6.12.2.2.15Finland104
6.12.2.2.16Croatia104
6.12.2.3South America104
6.12.2.3.1Chile-legalization measure approved in 2015104
6.12.2.3.2Colombia-legalization measure approved in 2015104
6.12.2.3.3Uruguay-legalization measure approved in December 2013104
6.12.2.4Rest of the world104
6.12.2.4.1Israel-legalization measure approved in December 2018104
6.12.2.4.2Australia-legalization measure approved in February 2016104
6.12.2.4.3Thailand105
6.12.2.4.4South Korea105
6.12.2.4.5Malaysia105
6.12.2.4.6South Africa105
6.13PORTER’S FIVE FORCES ANALYSIS105
TABLE 18CANNABIS MARKET: PORTER’S FIVE FORCES ANALYSIS106
6.13.1DEGREE OF COMPETITION106
6.13.2BARGAINING POWER OF SUPPLIERS106
6.13.3BARGAINING POWER OF BUYERS107
6.13.4THREAT OF SUBSTITUTES107
6.13.5THREAT OF NEW ENTRANTS107
6.14KEY STAKEHOLDERS AND BUYING CRITERIA107
6.14.1KEY STAKEHOLDERS IN BUYING PROCESS107
FIGURE 38INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR TOP APPLICATIONS108
TABLE 19INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR TOP APPLICATIONS (%)108
6.14.2BUYING CRITERIA108
FIGURE 39KEY CRITERIA FOR SELECTING SUPPLIER/VENDOR109
TABLE 20KEY CRITERIA FOR SELECTING SUPPLIER/VENDOR109
7CANNABIS MARKET, BY PRODUCT TYPE110
7.1INTRODUCTION111
FIGURE 40CANNABIS MARKET SHARE (VALUE), BY PRODUCT TYPE, 2022 VS 2027111
TABLE 21CANNABIS MARKET, BY PRODUCT TYPE, 2018–2021 (USD MILLION)111
TABLE 22CANNABIS MARKET, BY PRODUCT TYPE, 2022–2027 (USD MILLION)112
TABLE 23CANNABIS MARKET, BY PRODUCT TYPE, 2018–2021 (TONS)112
TABLE 24CANNABIS MARKET, BY PRODUCT TYPE, 2022–2027 (TONS)112
7.2FLOWERS113
7.2.1AUTOMATION AND SUSTAINABLE PACKAGING TO BE KEY TRENDS IN PRE-ROLL DOMAIN113
TABLE 25FLOWERS: CANNABIS MARKET, BY REGION, 2018–2021 (USD MILLION)114
TABLE 26FLOWERS: CANNABIS MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)115
TABLE 27FLOWERS: CANNABIS MARKET, BY REGION, 2018–2021 (TONS)115
TABLE 28FLOWERS: CANNABIS MARKET SIZE, BY REGION, 2022–2027 (TONS)115
7.3CONCENTRATES115
7.3.1VARIOUS DELIVERY METHODS RESULTED IN CONSUMER-FRIENDLY CANNABIS CONCENTRATES MARKET115
TABLE 29CONCENTRATES: CANNABIS MARKET, BY REGION, 2018–2021 (USD MILLION)117
TABLE 30CONCENTRATES: CANNABIS MARKET, BY REGION, 2022–2027 (USD MILLION)117
TABLE 31CONCENTRATES: CANNABIS MARKET, BY REGION, 2018–2021 (TONS)118
TABLE 32CONCENTRATES: CANNABIS MARKET SIZE, BY REGION, 2022–2027 (TONS)118
7.4EDIBLES118
7.4.1FOOD AND BEVERAGE MANUFACTURING COMPANIES VENTURE INTO CANNABIS-INFUSED EDIBLES118
TABLE 33EDIBLES: CANNABIS MARKET, BY REGION, 2018–2021 (USD MILLION)119
TABLE 34EDIBLES: CANNABIS MARKET, BY REGION, 2022–2027 (USD MILLION)120
TABLE 35EDIBLES: CANNABIS MARKET, BY REGION, 2018–2021 (TONS)120
TABLE 36EDIBLES: CANNABIS MARKET SIZE, BY REGION, 2022–2027 (TONS)120
7.5TOPICALS & TINCTURES120
7.5.1TOPICALS WITNESS INCREASED DEMAND IN SKINCARE INDUSTRY120
TABLE 37TOPICALS & TINCTURES: CANNABIS MARKET, BY REGION, 2018–2021 (USD MILLION)121
TABLE 38TOPICALS & TINCTURES: CANNABIS MARKET, BY REGION, 2022–2027 (USD MILLION)121
TABLE 39TOPICALS & TINCTURES: CANNABIS MARKET, BY REGION, 2018–2021 (TONS)122
TABLE 40TOPICALS & TINCTURES: CANNABIS MARKET SIZE, BY REGION, 2022–2027 (TONS)122
7.6OTHER PRODUCT TYPES122
TABLE 41OTHER PRODUCT TYPES: CANNABIS MARKET, BY REGION, 2018–2021 (USD MILLION)123
TABLE 42OTHER PRODUCT TYPES: CANNABIS MARKET, BY REGION, 2022–2027 (USD MILLION)123
TABLE 43OTHER PRODUCT TYPES: CANNABIS MARKET, BY REGION, 2018–2021 (TONS)123
TABLE 44OTHER PRODUCT TYPES: CANNABIS MARKET SIZE, BY REGION, 2022–2027 (TONS)124
8CANNABIS MARKET, BY COMPOUND125
8.1INTRODUCTION126
FIGURE 41CANNABIS MARKET SHARE (VALUE), BY COMPOUND, 2022 VS 2027126
TABLE 45CANNABIS MARKET, BY COMPOUND, 2018–2021 (USD MILLION)126
TABLE 46CANNABIS MARKET, BY COMPOUND, 2022–2027 (USD MILLION)126
8.2TETRAHYDROCANNABINOL (THC)-DOMINANT127
8.2.1INCREASING LEGALIZATION OF RECREATIONAL CANNABIS PROPELS THC-DOMINANT CANNABIS MARKET127
TABLE 47THC-DOMINANT: CANNABIS MARKET, BY REGION, 2018–2021 (USD MILLION)128
TABLE 48THC-DOMINANT: CANNABIS MARKET, BY REGION, 2022–2027 (USD MILLION)128
8.3CANNABIDIOL (CBD)-DOMINANT128
8.3.1INCREASED POPULARITY OF CBD EDIBLES TO DRIVE CBD-DOMINANT CANNABIS PRODUCTS MARKET128
TABLE 49CBD-DOMINANT: CANNABIS MARKET, BY REGION, 2018–2021 (USD MILLION)129
TABLE 50CBD-DOMINANT: CANNABIS MARKET, BY REGION, 2022–2027 (USD MILLION)129
8.4BALANCED THC & CBD130
8.4.1BALANCED THC & CBD STRAINS WITNESS GROWTH AS CBD DIMINISHES PSYCHOACTIVE PROPERTIES OF THC130
TABLE 51BALANCED THC & CBD: CANNABIS MARKET, BY REGION, 2018–2021 (USD MILLION)130
TABLE 52BALANCED THC & CBD: CANNABIS MARKET, BY REGION, 2022–2027 (USD MILLION)130
9CANNABIS MARKET, BY APPLICATION131
9.1INTRODUCTION132
FIGURE 42CANNABIS MARKET SHARE (VALUE), BY APPLICATION, 2022 VS 2027132
TABLE 53CANNABIS MARKET, BY APPLICATION, 2018–2021 (USD MILLION)132
TABLE 54CANNABIS MARKET, BY APPLICATION, 2022–2027 (USD MILLION)132
9.2MEDICAL133
9.2.1INCREASE IN CANNABIS USE FOR TREATMENT OF VARIOUS AILMENTS DRIVES DEMAND FOR MEDICAL CANNABIS133
9.2.1.1Pain management134
9.2.1.2Neurological health management134
9.2.1.3Mental health management135
9.2.1.4Other medical applications135
TABLE 55MEDICAL: CANNABIS MARKET, BY REGION, 2018–2021 (USD MILLION)137
TABLE 56MEDICAL: CANNABIS MARKET, BY REGION, 2022–2027 (USD MILLION)137
9.3RECREATIONAL137
9.3.1WIDER LEGALIZATION STATUS OF RECREATIONAL CANNABIS TO BOOST MARKET GROWTH137
TABLE 57RECREATIONAL: CANNABIS MARKET, BY REGION, 2018–2021 (USD MILLION)138
TABLE 58RECREATIONAL: CANNABIS MARKET, BY REGION, 2022–2027 (USD MILLION)139
10CANNABIS MARKET, BY REGION140
10.1INTRODUCTION141
FIGURE 43REGIONAL SNAPSHOT: NEW HOTSPOTS TO EMERGE IN EUROPE, 2022–2027142
TABLE 59CANNABIS MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)142
TABLE 60CANNABIS MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)142
TABLE 61CANNABIS MARKET SIZE, BY REGION, 2018–2021 (TONS)143
TABLE 62CANNABIS MARKET SIZE, BY REGION, 2022–2027 (TONS)143
10.2NORTH AMERICA143
FIGURE 44NORTH AMERICA: CANNABIS MARKET SNAPSHOT144
TABLE 63NORTH AMERICA: CANNABIS MARKET SIZE, BY COUNTRY, 2018–2021 (USD MILLION)144
TABLE 64NORTH AMERICA: CANNABIS MARKET SIZE, BY COUNTRY, 2022–2027 (USD MILLION)145
TABLE 65NORTH AMERICA: CANNABIS MARKET SIZE, BY APPLICATION, 2018–2021 (USD MILLION)145
TABLE 66NORTH AMERICA: CANNABIS MARKET SIZE, BY APPLICATION, 2022–2027 (USD MILLION)145
TABLE 67NORTH AMERICA: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)145
TABLE 68NORTH AMERICA: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)146
TABLE 69NORTH AMERICA: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2018–2021 (USD MILLION)146
TABLE 70NORTH AMERICA: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2022–2027 (USD MILLION)146
TABLE 71NORTH AMERICA: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2018–2021 (TONS)147
TABLE 72NORTH AMERICA: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2022–2027 (TONS)147
10.2.1US147
10.2.1.1Increase in mergers, investments, and sales drive cannabis market in US147
TABLE 73US: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)148
TABLE 74US: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)148
10.2.2CANADA148
10.2.2.1Presence of major players in Canada boosts growth during forecast period148
TABLE 75CANADA: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)149
TABLE 76CANADA: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)149
10.2.3MEXICO149
10.2.3.1Medical cannabis used for epilepsy treatment boosts Mexican cannabis market growth149
TABLE 77MEXICO: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)150
TABLE 78MEXICO: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)150
10.3EUROPE151
FIGURE 45EUROPE: CANNABIS MARKET SNAPSHOT152
TABLE 79EUROPE: CANNABIS MARKET SIZE, BY COUNTRY, 2018–2021 (USD MILLION)152
TABLE 80EUROPE: CANNABIS MARKET SIZE, BY COUNTRY, 2022–2027 (USD MILLION)153
TABLE 81EUROPE: CANNABIS MARKET SIZE, BY APPLICATION, 2018–2021 (USD MILLION)153
TABLE 82EUROPE: CANNABIS MARKET SIZE, BY APPLICATION, 2022–2027 (USD MILLION)153
TABLE 83EUROPE: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)153
TABLE 84EUROPE: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)154
TABLE 85EUROPE: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2018–2021 (USD MILLION)154
TABLE 86EUROPE: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2022–2027 (USD MILLION)154
TABLE 87EUROPE: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2018–2021 (TONS)154
TABLE 88EUROPE: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2022–2027 (TONS)155
10.3.1GERMANY155
10.3.1.1Health insurance coverage for cannabis use in medical treatments driving market155
TABLE 89GERMANY: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)156
TABLE 90GERMANY: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)156
10.3.2ITALY156
10.3.2.1Increase in demand for cannabis and issuance of import licenses to drive market156
TABLE 91ITALY: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)157
TABLE 92ITALY: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)157
10.3.3DENMARK157
10.3.3.1Huge demand for medical cannabis to drive Danish medical cannabis market157
TABLE 93DENMARK: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)158
TABLE 94DENMARK: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)158
10.3.4NETHERLANDS158
10.3.4.1Strong infrastructure and rise in export of medical cannabis to other countries drive market158
TABLE 95NETHERLANDS: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)159
TABLE 96NETHERLANDS: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)159
10.3.5FRANCE159
10.3.5.1Government providing finance to healthcare systems and refunds provided to patients159
TABLE 97FRANCE: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)160
TABLE 98FRANCE: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)160
10.3.6REST OF EUROPE160
TABLE 99REST OF EUROPE: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)161
TABLE 100REST OF EUROPE: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)162
10.4SOUTH AMERICA162
TABLE 101SOUTH AMERICA: CANNABIS MARKET SIZE, BY COUNTRY, 2018–2021 (USD MILLION)162
TABLE 102SOUTH AMERICA: CANNABIS MARKET SIZE, BY COUNTRY, 2022–2027 (USD MILLION)163
TABLE 103SOUTH AMERICA: CANNABIS MARKET SIZE, BY APPLICATION, 2018–2021 (USD MILLION)163
TABLE 104SOUTH AMERICA: CANNABIS MARKET SIZE, BY APPLICATION, 2022–2027 (USD MILLION)163
TABLE 105SOUTH AMERICA: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)163
TABLE 106SOUTH AMERICA: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)164
TABLE 107SOUTH AMERICA: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2018–2021 (USD MILLION)164
TABLE 108SOUTH AMERICA: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2022–2027 (USD MILLION)164
TABLE 109SOUTH AMERICA: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2018–2021 (TONS)165
TABLE 110SOUTH AMERICA: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2022–2027 (TONS)165
10.4.1CHILE165
10.4.1.1Rise in consumption of cannabis for medical usage driving market165
TABLE 111CHILE: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)166
TABLE 112CHILE: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)166
10.4.2COLOMBIA166
10.4.2.1Increased cannabis license distribution to companies drives market166
TABLE 113COLOMBIA: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)167
TABLE 114COLOMBIA: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)167
10.4.3URUGUAY167
10.4.3.1Fully legalized cannabis industry with eased regulations drives market167
TABLE 115URUGUAY: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)168
TABLE 116URUGUAY: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)168
10.4.4REST OF SOUTH AMERICA168
TABLE 117REST OF SOUTH AMERICA: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)169
TABLE 118REST OF SOUTH AMERICA: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)169
10.5ROW169
TABLE 119ROW: CANNABIS MARKET SIZE, BY COUNTRY, 2018–2021 (USD MILLION)169
TABLE 120ROW: CANNABIS MARKET SIZE, BY COUNTRY, 2022–2027 (USD MILLION)170
TABLE 121ROW: CANNABIS MARKET SIZE, BY APPLICATION, 2018–2021 (USD MILLION)170
TABLE 122ROW: CANNABIS MARKET SIZE, BY APPLICATION, 2022–2027 (USD MILLION)170
TABLE 123ROW: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)170
TABLE 124ROW: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)171
TABLE 125ROW: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2018–2021 (USD MILLION)171
TABLE 126ROW: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2022–2027 (USD MILLION)171
TABLE 127ROW: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2018–2021 (TONS)171
TABLE 128ROW: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2022–2027 (TONS)172
10.5.1ISRAEL172
10.5.1.1Technical innovations and increased exports to drive market172
TABLE 129ISRAEL: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)173
TABLE 130ISRAEL: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)173
10.5.2AUSTRALIA173
10.5.2.1Surge in epilepsy, chronic pain, and cancer patients resulted in market growth173
TABLE 131AUSTRALIA: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)174
TABLE 132AUSTRALIA: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)174
10.5.3OTHERS IN ROW174
TABLE 133OTHERS IN ROW: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)175
TABLE 134OTHERS IN ROW: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)175
11COMPETITIVE LANDSCAPE176
11.1OVERVIEW176
11.2MARKET SHARE ANALYSIS, 2021176
TABLE 135CANNABIS MARKET: DEGREE OF COMPETITION (FRAGMENTED)177
11.3SEGMENTAL REVENUE ANALYSIS OF KEY PLAYERS177
FIGURE 46SEGMENTAL REVENUE ANALYSIS OF KEY PLAYERS IN MARKET, 2017–2021 (USD MILLION)177
11.4KEY PLAYER STRATEGIES178
TABLE 136STRATEGIES ADOPTED BY KEY CANNABIS MANUFACTURERS178
11.5COMPANY EVALUATION QUADRANT (KEY PLAYERS)180
11.5.1STARS181
11.5.2EMERGING LEADERS181
11.5.3PERVASIVE PLAYERS181
11.5.4PARTICIPANTS181
FIGURE 47CANNABIS MARKET: COMPANY EVALUATION QUADRANT, 2021 (KEY PLAYERS)182
11.5.5PRODUCT FOOTPRINT182
TABLE 137COMPANY FOOTPRINT, BY APPLICATION182
TABLE 138COMPANY FOOTPRINT, BY TYPE183
TABLE 139COMPANY FOOTPRINT, BY REGION184
TABLE 140OVERALL COMPANY FOOTPRINT184
11.6CANNABIS MARKET: EVALUATION QUADRANT FOR STARTUPS/SMES, 2021185
11.6.1PROGRESSIVE COMPANIES185
11.6.2STARTING BLOCKS185
11.6.3RESPONSIVE COMPANIES185
11.6.4DYNAMIC COMPANIES185
FIGURE 48CANNABIS MARKET: COMPANY EVALUATION QUADRANT, 2021 (STARTUPS/SMES)186
11.6.5COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES186
TABLE 141CANNABIS MARKET: DETAILED LIST OF KEY STARTUP/SMES186
TABLE 142CANNABIS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES187
11.7PRODUCT LAUNCHES, DEALS, AND OTHER DEVELOPMENTS188
11.7.1PRODUCT LAUNCHES188
TABLE 143CANNABIS: PRODUCT LAUNCHES, 2019–2022188
11.7.2DEALS189
TABLE 144CANNABIS: DEALS, 2019–2022189
11.7.3OTHERS191
TABLE 145CANNABIS: OTHERS, 2019–2022191
12COMPANY PROFILES193
12.1INTRODUCTION193
12.2KEY PLAYER193
(Business overview, Products/Solutions/Services offered, Recent developments, New product launches, Deals, MnM view, Right to win, Strategic choices, and Weaknesses and competitive threats)*
12.2.1CANOPY GROWTH CORPORATION193
TABLE 146CANOPY GROWTH CORPORATION: BUSINESS OVERVIEW193
FIGURE 49CANOPY GROWTH CORPORATION: COMPANY SNAPSHOT194
TABLE 147CANOPY GROWTH CORPORATION: PRODUCTS OFFERED194
TABLE 148CANOPY GROWTH CORPORATION: NEW PRODUCT LAUNCHES196
TABLE 149CANOPY GROWTH CORPORATION: DEALS198
TABLE 150CANOPY GROWTH CORPORATION: OTHERS200
12.2.2CURALEAF202
TABLE 151CURALEAF: BUSINESS OVERVIEW202
FIGURE 50CURALEAF: COMPANY SNAPSHOT202
TABLE 152CURALEAF: PRODUCTS OFFERED203
TABLE 153CURALEAF: NEW PRODUCT LAUNCHES204
TABLE 154CURALEAF: DEALS204
TABLE 155CURALEAF: OTHERS205
12.2.3CRESCO LABS208
TABLE 156CRESCO LABS: BUSINESS OVERVIEW208
FIGURE 51CRESCO LABS: COMPANY SNAPSHOT208
TABLE 157CRESCO LABS: PRODUCTS OFFERED209
TABLE 158CRESCO LABS: NEW PRODUCT LAUNCHES210
TABLE 159CRESCO LABS: DEALS210
TABLE 160CRESCO LABS: OTHERS211
12.2.4GREEN THUMB INDUSTRIES214
TABLE 161GREEN THUMB INDUSTRIES: BUSINESS OVERVIEW214
FIGURE 52GREEN THUMB INDUSTRIES: COMPANY SNAPSHOT214
TABLE 162GREEN THUMB INDUSTRIES: PRODUCTS OFFERED215
TABLE 163GREEN THUMB INDUSTRIES: DEALS215
TABLE 164GREEN THUMB INDUSTRIES: OTHERS216
12.2.5TILRAY218
TABLE 165TILRAY: BUSINESS OVERVIEW218
FIGURE 53TILRAY: COMPANY SNAPSHOT218
TABLE 166TILRAY INC: PRODUCTS OFFERED219
TABLE 167TILRAY: NEW PRODUCT LAUNCHES219
TABLE 168TILRAY: DEALS220
TABLE 169TILRAY: OTHERS220
12.2.6TRULIEVE222
TABLE 170TRULIEVE: BUSINESS OVERVIEW222
FIGURE 54TRULIEVE: COMPANY SNAPSHOT222
TABLE 171TRULIEVE: PRODUCTS OFFERED223
TABLE 172TRULIEVE: DEALS223
TABLE 173TRULIEVE: OTHERS224
12.2.7AURORA CANNABIS INC.227
TABLE 174AURORA CANNABIS INC.: BUSINESS OVERVIEW227
FIGURE 55AURORA CANNABIS INC.: COMPANY SNAPSHOT227
TABLE 175AURORA CANNABIS INC.: PRODUCTS OFFERED228
TABLE 176AURORA CANNABIS INC.: NEW PRODUCT LAUNCHES229
TABLE 177AURORA CANNABIS INC.: DEALS230
TABLE 178AURORA CANNABIS INC.: OTHERS231
12.2.8MEDMEN233
TABLE 179MEDMEN: BUSINESS OVERVIEW233
FIGURE 56MEDMEN: COMPANY SNAPSHOT233
TABLE 180MEDMEN: PRODUCTS OFFERED234
TABLE 181MEDMEN: OTHERS234
12.2.9UNRIVALED BRAND INC.236
TABLE 182UNRIVALED BRAND INC.: BUSINESS OVERVIEW236
FIGURE 57UNRIVALED BRAND INC.: COMPANY SNAPSHOT236
TABLE 183UNRIVALED BRAND INC.: PRODUCTS OFFERED237
TABLE 184UNRIVALED BRAND INC.: DEALS237
TABLE 185UNRIVALED BRAND INC.: OTHERS238
12.2.10ORGANIGRAM HOLDINGS INC.240
TABLE 186ORGANIGRAM HOLDINGS INC.: BUSINESS OVERVIEW240
FIGURE 58ORGANIGRAM HOLDINGS INC.: COMPANY SNAPSHOT240
TABLE 187ORGANIGRAM HOLDINGS INC.: PRODUCTS OFFERED241
TABLE 188ORGANIGRAM HOLDINGS INC.: PRODUCT LAUNCH241
TABLE 189ORGANIGRAM HOLDINGS INC.: DEALS242
TABLE 190ORGANIGRAM HOLDINGS INC.: OTHERS242
12.2.11STENOCARE244
TABLE 191STENOCARE: BUSINESS OVERVIEW244
FIGURE 59STENOCARE: COMPANY SNAPSHOT244
TABLE 192STENOCARE: PRODUCTS OFFERED244
TABLE 193STENOCARE: DEALS245
TABLE 194STENOCARE: OTHERS245
12.2.12VIVO CANNABIS INC.247
TABLE 195VIVO CANNABIS INC.: BUSINESS OVERVIEW247
FIGURE 60VIVO CANNABIS INC.: COMPANY SNAPSHOT247
TABLE 196VIVO CANNABIS INC.: PRODUCTS OFFERED248
TABLE 197VIVO CANNABIS INC.: NEW PRODUCT LAUNCHES249
TABLE 198VIVO CANNABIS INC.: DEALS250
TABLE 199VIVO CANNABIS INC.: OTHERS251
12.2.13TERRASCEND252
TABLE 200TERRASCEND: BUSINESS OVERVIEW252
FIGURE 61TERRASCEND: COMPANY SNAPSHOT252
TABLE 201TERRASCEND: PRODUCTS OFFERED253
TABLE 202TERRASCEND: DEALS254
TABLE 203TERRASCEND: OTHERS255
12.2.14HEXO CORP256
TABLE 204HEXO CORP: BUSINESS OVERVIEW256
FIGURE 62HEXO CORP: COMPANY SNAPSHOT256
TABLE 205HEXO CORP: PRODUCTS OFFERED257
TABLE 206HEXO CORP: NEW PRODUCT LAUNCHES257
TABLE 207HEXO CORP: DEALS258
TABLE 208HEXO CORP: OTHERS259
12.2.15VILLAGE FARMS INTERNATIONAL INC.260
TABLE 209VILLAGE FARMS INTERNATIONAL INC.: BUSINESS OVERVIEW260
FIGURE 63VILLAGE FARMS INTERNATIONAL INC.: COMPANY SNAPSHOT261
TABLE 210VILLAGE FARMS INTERNATIONAL INC.: PRODUCTS OFFERED261
TABLE 211VILLAGE FARMS INTERNATIONAL INC.: OTHERS261
12.2.16VERANO263
TABLE 212VERANO: BUSINESS OVERVIEW263
FIGURE 64VERANO: COMPANY SNAPSHOT263
TABLE 213VERANO: PRODUCTS OFFERED263
TABLE 214VERANO: DEALS264
TABLE 215VERANO: OTHERS266
12.3OTHER PLAYERS (SMES/STARTUPS)269
12.3.1THE CRONOS GROUP269
TABLE 216THE CRONOS GROUP: BUSINESS OVERVIEW269
FIGURE 65THE CRONOS GROUP: COMPANY SNAPSHOT269
TABLE 217THE CRONOS GROUP: PRODUCTS OFFERED270
TABLE 218THE CRONOS GROUP: DEALS271
TABLE 219THE CRONOS GROUP: OTHERS272
12.3.2MEDICAL MARIJUANA, INC.273
TABLE 220MEDICAL MARIJUANA, INC.: BUSINESS OVERVIEW273
FIGURE 66MEDICAL MARIJUANA, INC.: COMPANY SNAPSHOT273
TABLE 221MEDICAL MARIJUANA, INC.: PRODUCTS OFFERED273
TABLE 222MEDICAL MARIJUANA, INC.: NEW PRODUCT LAUNCHES274
TABLE 223MEDICAL MARIJUANA, INC.: DEALS275
TABLE 224MEDICAL MARIJUANA, INC.: OTHERS275
12.3.3ECOFIBRE LIMITED277
TABLE 225ECOFIBRE LIMITED: BUSINESS OVERVIEW277
FIGURE 67ECOFIBRE LIMITED: COMPANY SNAPSHOT277
TABLE 226ECOFIBRE LIMITED: PRODUCTS OFFERED278
TABLE 227ECOFIBRE LIMITED: OTHERS279
12.3.4INDIVA280
TABLE 228INDIVA: BUSINESS OVERVIEW280
FIGURE 68INDIVA: COMPANY SNAPSHOT280
TABLE 229INDIVA: PRODUCTS OFFERED280
TABLE 230INDIVA: NEW PRODUCT LAUNCHES281
TABLE 231INDIVA: DEALS282
TABLE 232INDIVA: OTHERS283
12.3.5TIKUN OLAM-CANNBIT PHARMACEUTICALS LTD.284
TABLE 233TIKUN OLAM-CANNBIT PHARMACEUTICALS LTD.: BUSINESS OVERVIEW284
TABLE 234TIKUN OLAM-CANNBIT PHARMACEUTICALS LTD.: PRODUCTS OFFERED284
12.3.6MARICANN GROUP INC286
TABLE 235MARICANN GROUP INC: BUSINESS OVERVIEW286
TABLE 236MARICANN GROUP INC: PRODUCTS OFFERED286
12.3.7SATIPHARM288
12.3.8CANNABLISS ORGANIC LLC288
12.3.9CONNECTED CANNABIS CO.288
12.3.10JUSTICE C
The cannabis industry is growing rapidly and witnessing a double-digit growth rate globally. There are several major companies operating in the cannabis segment that dominate their respective markets. Thus, companies are competing to gain a significant market share. The leading players in the cannabis market and medical industry are undertaking inorganic growth strategies, such as expansions & investments and acquisitions—to increase their profits and market shares. For instance, in May 2020, Aurora Cannabis Inc. completed the acquisition of Reliva LLC (US), a leader in the sales of hemp-derived CBD products in the US. The acquisition took place for USD 40 million of Aurora's common shares. This acquisition would enable the company to strengthen its position in the market and increase profitability.
“By application, the recreational segment is projected to grow at the highest CAGR during the forecast period.”
Recreational cannabis demand is increasing continuously driven by Gen Z consumers. A small but encouraging portion of cannabis products are being sold to women due to a shift in public opinion, and this percentage is predicted to increase over time. Moreover, legalization has have led to a trend toward cannabis-related tourism, with locations producing novel holiday items to entice clients and increasing travel bookings to cannabis-legal destinations.
“By compound, the THC-dominant segment is estimated to account for the largest share.”
THC strain is used for both medical and recreational applications, which increases its demand among manufacturers as well as consumers. Growing Together Research Inc., an Indiana-based biotechnology business, has created a new technique for genetically regulating the expression of Delta-9-THC in cannabis, including the capacity to boost cannabinoid levels in marijuana varieties grown for recreational or medical purposes. Moreover, other forms of THC, such as delta-8-THC, are gaining popularity in addition to the conventional version.
“The Europe region is projected to grow at the highest CAGR during the forecast period”
The market in Europe is majorly driven by the awareness of medical benefits of cannabis in the region coupled with the healthcare system present in several European countries that covers the health expenditure of most patients in these regions. As the legalization of cannabis in European countries is at a nascent stage, this creates a considerable opportunity for companies to establish themselves in the region. Since the beginning of 2019, the European cannabis market has witnessed multiple mergers and acquisitions involving companies focused on medical cannabis. Like in the starting of 2021 medical cannabis firm GW Pharmaceutical was acquired by Jazz Pharmaceutical for USD 6.15 Billion.
Break-up of Primaries:
By Value Chain Side: Demand Side-59%, Supply Side-41%
By Designation: CXOs-31%, Managers – 24%, D-Level- 30%, and Executives- 45%
By Region: Europe - 25%, Asia Pacific – 15%, North America - 45%, RoW – 5%, South America-10%
Leading players profiled in this report:
•Canopy Growth Corporation (Canada)
•Aurora Cannabis Inc. (Canada)
•Medmen Enterprise Inc. (US)
•Tilray Inc. (US)
•Unrivaled Brand Inc. (US)
•VIVO Cannabis Inc. (Canada)
•The Cronos Group (Canada)
•Medical Marijuana Inc. (US)
•Stenocare (Denmark)
•Trulieve (US)
•Organigrams Holding Inc. (Canada)
•Cresco Labs (US)
•Maricann Group Inc. (Canada)
•Indiva (Canada)
•Hexo Corp. (Canada)
•Ecofibre Limited (Australia)
•Curaleaf Holdings Inc. (US)
•Harvest Health and Recreation (US)
•Green Thumb Industries (US)
•TerrAscend (Canada)
Research Coverage:
The report segments the cannabis market on the basis on product type, application, compound, and region. In terms of insights, this report has focused on various levels of analyses—the competitive landscape, end-use analysis, and company profiles, which together comprise and discuss views on the emerging & high-growth segments of the global cannabis, high-growth regions, countries, government initiatives, drivers, restraints, opportunities, and challenges.
Reasons to buy this report:
•To get a comprehensive overview of the cannabis market
•To gain wide-ranging information about the top players in this industry, their product portfolios, and key strategies adopted by them
•To gain insights about the major countries/regions in which the cannabis market is flourishing
1INTRODUCTION36
1.1STUDY OBJECTIVES36
1.2MARKET DEFINITION36
1.3STUDY SCOPE37
FIGURE 1MARKET SEGMENTATION37
1.3.1INCLUSIONS AND EXCLUSIONS37
1.3.2REGIONS COVERED38
1.3.3YEARS CONSIDERED38
1.4CURRENCY CONSIDERED39
TABLE 1USD EXCHANGE RATES CONSIDERED, 2017–202139
1.5STAKEHOLDERS39
1.6SUMMARY OF CHANGES40
2RESEARCH METHODOLOGY41
2.1RESEARCH DATA41
FIGURE 2CANNABIS MARKET: RESEARCH DESIGN41
2.1.1SECONDARY DATA42
2.1.1.1Key data from secondary sources42
2.1.2PRIMARY DATA43
2.1.2.1Key data from primary sources43
2.1.2.2Key industry insights44
2.1.2.3Breakdown of primary interviews44
FIGURE 3BREAKDOWN OF PRIMARY INTERVIEWS BY COMPANY TYPE, DESIGNATION, AND REGION44
2.2MARKET SIZE ESTIMATION45
FIGURE 4CANNABIS MARKET SIZE ESTIMATION, BY TYPE (SUPPLY-SIDE)46
FIGURE 5CANNABIS MARKET SIZE ESTIMATION (DEMAND-SIDE)46
2.2.1MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH47
FIGURE 6CANNABIS MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH47
2.2.2MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH47
FIGURE 7CANNABIS MARKET SIZE ESTIMATION: TOP-DOWN APPROACH48
2.3DATA TRIANGULATION49
FIGURE 8DATA TRIANGULATION49
2.4ASSUMPTIONS50
2.5RESEARCH LIMITATIONS AND ASSOCIATED RISKS51
3EXECUTIVE SUMMARY52
TABLE 2CANNABIS MARKET SHARE SNAPSHOT, 2022 VS. 2027 (USD MILLION)52
FIGURE 9CANNABIS MARKET SIZE, BY APPLICATION, 2022 VS. 2027 (USD MILLION)53
FIGURE 10CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2022 VS. 2027 (USD MILLION)53
FIGURE 11CANNABIS MARKET SIZE, BY COMPOUND, 2022 VS. 2027 (USD MILLION)54
FIGURE 12CANNABIS MARKET SHARE AND GROWTH RATE (VALUE), BY REGION, 202154
4PREMIUM INSIGHTS56
4.1ATTRACTIVE OPPORTUNITIES IN CANNABIS MARKET56
FIGURE 13GROWING MEDICINAL APPLICATIONS AND INCREASING LEGALIZATION OF CANNABIS CREATE OPPORTUNITIES IN MARKET56
4.2CANNABIS MARKET: MAJOR REGIONAL SUBMARKETS56
FIGURE 14NORTH AMERICA ACCOUNTED FOR LARGEST SHARE GLOBALLY IN 202156
4.3NORTH AMERICA: CANNABIS MARKET, BY COMPOUND AND COUNTRY57
FIGURE 15IN 2021, US ACCOUNTED FOR LARGEST SHARE IN NORTH AMERICA57
4.4CANNABIS MARKET, BY APPLICATION57
FIGURE 16RECREATIONAL SEGMENT TO DOMINATE CANNABIS MARKET DURING FORECAST PERIOD57
4.5CANNABIS MARKET, BY COMPOUND58
FIGURE 17TETRAHYDROCANNABINOL (THC)-DOMINANT COMPOUND TO DOMINATE CANNABIS MARKET DURING FORECAST PERIOD58
4.6CANNABIS MARKET, BY PRODUCT TYPE AND REGION58
FIGURE 18NORTH AMERICA TO DOMINATE CANNABIS MARKET DURING FORECAST PERIOD58
5MARKET OVERVIEW59
5.1INTRODUCTION59
5.2MACROECONOMIC INDICATORS59
5.2.1INCREASE IN AGING POPULATION59
FIGURE 19INCREASING POPULATION OF INDIVIDUALS AGED 60 AND ABOVE (2021–2021)60
5.2.2ECONOMIC DOWNTURN60
FIGURE 20UNEMPLOYMENT AS A PERCENTAGE OF TOTAL LABOR FORCE (2010–2021)61
5.3MARKET DYNAMICS62
FIGURE 21CANNABIS MARKET DYNAMICS62
5.3.1DRIVERS62
5.3.1.1Rising cannabis demand for medicinal applications62
5.3.1.2Legalization of cannabis and rise in social acceptance63
FIGURE 22GLOBAL CANNABIS REGULATORY OVERVIEW INDICATING LEGALITY OF MEDICAL RECREATIONAL CANNABIS, 202064
5.3.1.3Growth in R&D activities and technological advancements to be precursors for cannabis business64
5.3.1.4Rising global cannabis sales helping online retailers expand66
5.3.2RESTRAINTS66
5.3.2.1Complex regulatory structure for use of cannabis66
5.3.2.2Problems associated with high dose of cannabis consumption67
5.3.2.3Stigmatization of cannabis market67
5.3.2.4Profit margins of manufacturers shrinks as cannabis prices fall68
FIGURE 23AVERAGE SELLING PRICES OF CANNABIS, 2019–202268
5.3.3OPPORTUNITIES69
5.3.3.1Emergence of cannabis legalization in Asia Pacific69
5.3.3.2Edibles, led by gummies and chocolates, to present additional growth opportunities for cannabis business70
5.3.3.3Inorganic growth strategies adopted by US cannabis companies70
5.3.4CHALLENGES71
5.3.4.1Intensive water consumption and inability to maintain consistency during cannabis cultivation71
5.3.4.2Cannabis-producing businesses face financing difficulties in US71
5.3.4.3Advertising and marketing restrictions in US72
5.3.4.4Supply chain challenges associated with cannabis in US72
6INDUSTRY TRENDS73
6.1INTRODUCTION73
6.2VALUE CHAIN73
6.2.1RESEARCH AND PRODUCT DEVELOPMENT73
6.2.2RAW MATERIAL SOURCING73
6.2.3PRODUCTION74
6.2.4PACKAGING, STORAGE, AND DISTRIBUTION74
6.2.5RETAIL74
FIGURE 24CANNABIS MARKET: VALUE CHAIN75
6.3SUPPLY CHAIN ANALYSIS75
FIGURE 25CANNABIS MARKET: SUPPLY CHAIN75
6.4TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES76
6.4.1REVENUE SHIFT AND NEW REVENUE POCKETS IN CANNABIS MARKET76
FIGURE 26REVENUE SHIFT IMPACTING CANNABIS MARKET76
6.5MARKET MAPPING AND ECOSYSTEM OF CANNABIS MARKET76
6.5.1DEMAND-SIDE76
6.5.2SUPPLY-SIDE77
FIGURE 27CANNABIS MARKET ECOSYSTEM MAP77
6.5.3ECOSYSTEM MAP77
TABLE 3CANNABIS MARKET: ECOSYSTEM77
6.6TECHNOLOGY ANALYSIS79
6.6.1LED GLOW LIGHT79
6.6.2NANOENCAPSULATION79
6.6.3ARTIFICIAL INTELLIGENCE AND BLOCKCHAIN80
FIGURE 28PROCESSES TRACKED BY USING SEED-TO-SALE TRACKER81
6.6.4CROP STEERING81
6.6.5VERTICAL FARMING82
6.6.6INNOVATIVE HARDWARE TECH DEVICES82
6.6.7IOT AUTOMATION83
6.6.8GENETIC ENGINEERING83
6.7PRICING ANALYSIS84
6.7.1SELLING PRICES CHARGED BY KEY PLAYERS IN TERMS OF PRODUCT TYPE84
FIGURE 29SELLING PRICES OF KEY PLAYERS FOR CANNABIS PRODUCT TYPE84
TABLE 4SELLING PRICE OF KEY PLAYERS FOR PRODUCT TYPE85
FIGURE 30AVERAGE SELLING PRICE IN KEY REGIONS, BY PRODUCT TYPE, 2018–2021 (USD/KG)85
TABLE 5FLOWER: AVERAGE SELLING PRICE, BY REGION, 2018–2021 (USD/KG)86
TABLE 6CONCENTRATES: AVERAGE SELLING PRICE, BY REGION, 2018–2021 (USD/KG)86
TABLE 7EDIBLES: AVERAGE SELLING PRICE, BY REGION, 2018–2021 (USD/KG)86
TABLE 8TOPICALS & TINCTURES: AVERAGE SELLING PRICE, BY REGION, 2018–2021 (USD/KG)86
TABLE 9OTHER PRODUCT TYPES: AVERAGE SELLING PRICE, BY REGION, 2018–2021 (USD/KG)87
6.8CANNABIS MARKET: PATENT ANALYSIS87
FIGURE 31NUMBER OF PATENTS GRANTED FOR CANNABIS MARKET, 2011–202187
FIGURE 32TOP PATENT APPLICANTS FOR CANNABIS MARKET, 2019–202288
FIGURE 33REGIONAL ANALYSIS OF PATENTS GRANTED FOR CANNABIS MARKET, 2019–202288
6.8.1LIST OF MAJOR PATENTS88
TABLE 10LIST OF A FEW PATENTS IN CANNABIS MARKET, 2019–202288
6.9TRADE ANALYSIS: CANNABIS MARKET90
6.9.1EXPORT SCENARIO OF HEMP90
FIGURE 34HEMP EXPORT, BY KEY COUNTRY, 2017–2021 (USD THOUSAND)90
TABLE 11EXPORT DATA OF HEMP FOR KEY COUNTRIES, 2021 (VALUE AND VOLUME)90
6.9.2IMPORT SCENARIO OF HEMP91
FIGURE 35HEMP IMPORT, BY KEY COUNTRY, 2017–2021 (USD THOUSAND)91
TABLE 12IMPORT DATA OF HEMP FOR KEY COUNTRIES, 2021 (VALUE AND VOLUME)91
6.10CASE STUDIES: CANNABIS MARKET92
6.10.1FILTER420: ATTEMPTS TO BUILD BRAND VALUE92
6.10.2ONYX AGRONOMICS: PRECISION CANNABIS FACILITY92
6.11KEY CONFERENCES AND EVENTS, 2022–202393
TABLE 13KEY CONFERENCES AND EVENTS IN CANNABIS MARKET93
6.12TARIFF AND REGULATORY LANDSCAPE94
6.12.1REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS94
TABLE 14NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS94
TABLE 15EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS95
TABLE 16SOUTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS95
TABLE 17REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS96
6.12.2REGULATORY FRAMEWORK96
FIGURE 36GLOBAL CANNABIS REGULATORY OVERVIEW INDICATING LEGALITY OF MEDICAL RECREATIONAL CANNABIS, 202296
6.12.2.1North America97
FIGURE 37US CANNABIS REGULATORY OVERVIEW, 202297
6.12.2.1.1US97
6.12.2.1.1.1Alaska-legalization measure approved in November 201497
6.12.2.1.1.2Arizona-legalization measure approved in November 202097
6.12.2.1.1.3California-legalization measure approved in November 201697
6.12.2.1.1.4Colorado-legalization measure approved in November 201298
6.12.2.1.1.5Connecticut-legalization measure approved in June 202198
6.12.2.1.1.6Guam-legalization measure approved in April 201998
6.12.2.1.1.7Illinois-legalization measure approved in May 201998
6.12.2.1.1.8Maine-legalization measure approved in November 201698
6.12.2.1.1.9Massachusetts-legalization measure approved in November 201698
6.12.2.1.1.10Michigan-legalization measure approved in November 201898
6.12.2.1.1.11Montana-legalization measure approved in January 202199
6.12.2.1.1.12New Jersey-legalization measure approved in November 202099
6.12.2.1.1.13New Mexico- legalization measure approved in April 202199
6.12.2.1.1.14New York-legalization measure approved in March 202199
6.12.2.1.1.15Oregon-legalization measure approved in November 201499
6.12.2.1.1.16Rhode Island-legalization measure approved in May 2022100
6.12.2.1.1.17Vermont-legalization measure approved in January 2018100
6.12.2.1.1.18Virginia-legalization measure approved in April 2021100
6.12.2.1.1.19Washington-legalization measure approved in November 2012100
6.12.2.1.2Canada100
6.12.2.2Europe101
6.12.2.2.1German-legalization measure approved in 2017101
6.12.2.2.2Italy-legalization measure approved in 2014101
6.12.2.2.3Denmark-legalization measure approved in January 2018101
6.12.2.2.4Malta-legalization measure approved in January 2018101
6.12.2.2.5Netherlands-legalization measure approved in January 2013102
6.12.2.2.6France-legalization measure approved in March 2022102
6.12.2.2.7Switzerland102
6.12.2.2.8UK103
6.12.2.2.9Belgium103
6.12.2.2.10Poland103
6.12.2.2.11Czech Republic103
6.12.2.2.12Spain103
6.12.2.2.13Austria103
6.12.2.2.14Norway103
6.12.2.2.15Finland104
6.12.2.2.16Croatia104
6.12.2.3South America104
6.12.2.3.1Chile-legalization measure approved in 2015104
6.12.2.3.2Colombia-legalization measure approved in 2015104
6.12.2.3.3Uruguay-legalization measure approved in December 2013104
6.12.2.4Rest of the world104
6.12.2.4.1Israel-legalization measure approved in December 2018104
6.12.2.4.2Australia-legalization measure approved in February 2016104
6.12.2.4.3Thailand105
6.12.2.4.4South Korea105
6.12.2.4.5Malaysia105
6.12.2.4.6South Africa105
6.13PORTER’S FIVE FORCES ANALYSIS105
TABLE 18CANNABIS MARKET: PORTER’S FIVE FORCES ANALYSIS106
6.13.1DEGREE OF COMPETITION106
6.13.2BARGAINING POWER OF SUPPLIERS106
6.13.3BARGAINING POWER OF BUYERS107
6.13.4THREAT OF SUBSTITUTES107
6.13.5THREAT OF NEW ENTRANTS107
6.14KEY STAKEHOLDERS AND BUYING CRITERIA107
6.14.1KEY STAKEHOLDERS IN BUYING PROCESS107
FIGURE 38INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR TOP APPLICATIONS108
TABLE 19INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR TOP APPLICATIONS (%)108
6.14.2BUYING CRITERIA108
FIGURE 39KEY CRITERIA FOR SELECTING SUPPLIER/VENDOR109
TABLE 20KEY CRITERIA FOR SELECTING SUPPLIER/VENDOR109
7CANNABIS MARKET, BY PRODUCT TYPE110
7.1INTRODUCTION111
FIGURE 40CANNABIS MARKET SHARE (VALUE), BY PRODUCT TYPE, 2022 VS 2027111
TABLE 21CANNABIS MARKET, BY PRODUCT TYPE, 2018–2021 (USD MILLION)111
TABLE 22CANNABIS MARKET, BY PRODUCT TYPE, 2022–2027 (USD MILLION)112
TABLE 23CANNABIS MARKET, BY PRODUCT TYPE, 2018–2021 (TONS)112
TABLE 24CANNABIS MARKET, BY PRODUCT TYPE, 2022–2027 (TONS)112
7.2FLOWERS113
7.2.1AUTOMATION AND SUSTAINABLE PACKAGING TO BE KEY TRENDS IN PRE-ROLL DOMAIN113
TABLE 25FLOWERS: CANNABIS MARKET, BY REGION, 2018–2021 (USD MILLION)114
TABLE 26FLOWERS: CANNABIS MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)115
TABLE 27FLOWERS: CANNABIS MARKET, BY REGION, 2018–2021 (TONS)115
TABLE 28FLOWERS: CANNABIS MARKET SIZE, BY REGION, 2022–2027 (TONS)115
7.3CONCENTRATES115
7.3.1VARIOUS DELIVERY METHODS RESULTED IN CONSUMER-FRIENDLY CANNABIS CONCENTRATES MARKET115
TABLE 29CONCENTRATES: CANNABIS MARKET, BY REGION, 2018–2021 (USD MILLION)117
TABLE 30CONCENTRATES: CANNABIS MARKET, BY REGION, 2022–2027 (USD MILLION)117
TABLE 31CONCENTRATES: CANNABIS MARKET, BY REGION, 2018–2021 (TONS)118
TABLE 32CONCENTRATES: CANNABIS MARKET SIZE, BY REGION, 2022–2027 (TONS)118
7.4EDIBLES118
7.4.1FOOD AND BEVERAGE MANUFACTURING COMPANIES VENTURE INTO CANNABIS-INFUSED EDIBLES118
TABLE 33EDIBLES: CANNABIS MARKET, BY REGION, 2018–2021 (USD MILLION)119
TABLE 34EDIBLES: CANNABIS MARKET, BY REGION, 2022–2027 (USD MILLION)120
TABLE 35EDIBLES: CANNABIS MARKET, BY REGION, 2018–2021 (TONS)120
TABLE 36EDIBLES: CANNABIS MARKET SIZE, BY REGION, 2022–2027 (TONS)120
7.5TOPICALS & TINCTURES120
7.5.1TOPICALS WITNESS INCREASED DEMAND IN SKINCARE INDUSTRY120
TABLE 37TOPICALS & TINCTURES: CANNABIS MARKET, BY REGION, 2018–2021 (USD MILLION)121
TABLE 38TOPICALS & TINCTURES: CANNABIS MARKET, BY REGION, 2022–2027 (USD MILLION)121
TABLE 39TOPICALS & TINCTURES: CANNABIS MARKET, BY REGION, 2018–2021 (TONS)122
TABLE 40TOPICALS & TINCTURES: CANNABIS MARKET SIZE, BY REGION, 2022–2027 (TONS)122
7.6OTHER PRODUCT TYPES122
TABLE 41OTHER PRODUCT TYPES: CANNABIS MARKET, BY REGION, 2018–2021 (USD MILLION)123
TABLE 42OTHER PRODUCT TYPES: CANNABIS MARKET, BY REGION, 2022–2027 (USD MILLION)123
TABLE 43OTHER PRODUCT TYPES: CANNABIS MARKET, BY REGION, 2018–2021 (TONS)123
TABLE 44OTHER PRODUCT TYPES: CANNABIS MARKET SIZE, BY REGION, 2022–2027 (TONS)124
8CANNABIS MARKET, BY COMPOUND125
8.1INTRODUCTION126
FIGURE 41CANNABIS MARKET SHARE (VALUE), BY COMPOUND, 2022 VS 2027126
TABLE 45CANNABIS MARKET, BY COMPOUND, 2018–2021 (USD MILLION)126
TABLE 46CANNABIS MARKET, BY COMPOUND, 2022–2027 (USD MILLION)126
8.2TETRAHYDROCANNABINOL (THC)-DOMINANT127
8.2.1INCREASING LEGALIZATION OF RECREATIONAL CANNABIS PROPELS THC-DOMINANT CANNABIS MARKET127
TABLE 47THC-DOMINANT: CANNABIS MARKET, BY REGION, 2018–2021 (USD MILLION)128
TABLE 48THC-DOMINANT: CANNABIS MARKET, BY REGION, 2022–2027 (USD MILLION)128
8.3CANNABIDIOL (CBD)-DOMINANT128
8.3.1INCREASED POPULARITY OF CBD EDIBLES TO DRIVE CBD-DOMINANT CANNABIS PRODUCTS MARKET128
TABLE 49CBD-DOMINANT: CANNABIS MARKET, BY REGION, 2018–2021 (USD MILLION)129
TABLE 50CBD-DOMINANT: CANNABIS MARKET, BY REGION, 2022–2027 (USD MILLION)129
8.4BALANCED THC & CBD130
8.4.1BALANCED THC & CBD STRAINS WITNESS GROWTH AS CBD DIMINISHES PSYCHOACTIVE PROPERTIES OF THC130
TABLE 51BALANCED THC & CBD: CANNABIS MARKET, BY REGION, 2018–2021 (USD MILLION)130
TABLE 52BALANCED THC & CBD: CANNABIS MARKET, BY REGION, 2022–2027 (USD MILLION)130
9CANNABIS MARKET, BY APPLICATION131
9.1INTRODUCTION132
FIGURE 42CANNABIS MARKET SHARE (VALUE), BY APPLICATION, 2022 VS 2027132
TABLE 53CANNABIS MARKET, BY APPLICATION, 2018–2021 (USD MILLION)132
TABLE 54CANNABIS MARKET, BY APPLICATION, 2022–2027 (USD MILLION)132
9.2MEDICAL133
9.2.1INCREASE IN CANNABIS USE FOR TREATMENT OF VARIOUS AILMENTS DRIVES DEMAND FOR MEDICAL CANNABIS133
9.2.1.1Pain management134
9.2.1.2Neurological health management134
9.2.1.3Mental health management135
9.2.1.4Other medical applications135
TABLE 55MEDICAL: CANNABIS MARKET, BY REGION, 2018–2021 (USD MILLION)137
TABLE 56MEDICAL: CANNABIS MARKET, BY REGION, 2022–2027 (USD MILLION)137
9.3RECREATIONAL137
9.3.1WIDER LEGALIZATION STATUS OF RECREATIONAL CANNABIS TO BOOST MARKET GROWTH137
TABLE 57RECREATIONAL: CANNABIS MARKET, BY REGION, 2018–2021 (USD MILLION)138
TABLE 58RECREATIONAL: CANNABIS MARKET, BY REGION, 2022–2027 (USD MILLION)139
10CANNABIS MARKET, BY REGION140
10.1INTRODUCTION141
FIGURE 43REGIONAL SNAPSHOT: NEW HOTSPOTS TO EMERGE IN EUROPE, 2022–2027142
TABLE 59CANNABIS MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)142
TABLE 60CANNABIS MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)142
TABLE 61CANNABIS MARKET SIZE, BY REGION, 2018–2021 (TONS)143
TABLE 62CANNABIS MARKET SIZE, BY REGION, 2022–2027 (TONS)143
10.2NORTH AMERICA143
FIGURE 44NORTH AMERICA: CANNABIS MARKET SNAPSHOT144
TABLE 63NORTH AMERICA: CANNABIS MARKET SIZE, BY COUNTRY, 2018–2021 (USD MILLION)144
TABLE 64NORTH AMERICA: CANNABIS MARKET SIZE, BY COUNTRY, 2022–2027 (USD MILLION)145
TABLE 65NORTH AMERICA: CANNABIS MARKET SIZE, BY APPLICATION, 2018–2021 (USD MILLION)145
TABLE 66NORTH AMERICA: CANNABIS MARKET SIZE, BY APPLICATION, 2022–2027 (USD MILLION)145
TABLE 67NORTH AMERICA: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)145
TABLE 68NORTH AMERICA: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)146
TABLE 69NORTH AMERICA: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2018–2021 (USD MILLION)146
TABLE 70NORTH AMERICA: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2022–2027 (USD MILLION)146
TABLE 71NORTH AMERICA: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2018–2021 (TONS)147
TABLE 72NORTH AMERICA: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2022–2027 (TONS)147
10.2.1US147
10.2.1.1Increase in mergers, investments, and sales drive cannabis market in US147
TABLE 73US: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)148
TABLE 74US: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)148
10.2.2CANADA148
10.2.2.1Presence of major players in Canada boosts growth during forecast period148
TABLE 75CANADA: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)149
TABLE 76CANADA: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)149
10.2.3MEXICO149
10.2.3.1Medical cannabis used for epilepsy treatment boosts Mexican cannabis market growth149
TABLE 77MEXICO: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)150
TABLE 78MEXICO: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)150
10.3EUROPE151
FIGURE 45EUROPE: CANNABIS MARKET SNAPSHOT152
TABLE 79EUROPE: CANNABIS MARKET SIZE, BY COUNTRY, 2018–2021 (USD MILLION)152
TABLE 80EUROPE: CANNABIS MARKET SIZE, BY COUNTRY, 2022–2027 (USD MILLION)153
TABLE 81EUROPE: CANNABIS MARKET SIZE, BY APPLICATION, 2018–2021 (USD MILLION)153
TABLE 82EUROPE: CANNABIS MARKET SIZE, BY APPLICATION, 2022–2027 (USD MILLION)153
TABLE 83EUROPE: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)153
TABLE 84EUROPE: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)154
TABLE 85EUROPE: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2018–2021 (USD MILLION)154
TABLE 86EUROPE: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2022–2027 (USD MILLION)154
TABLE 87EUROPE: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2018–2021 (TONS)154
TABLE 88EUROPE: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2022–2027 (TONS)155
10.3.1GERMANY155
10.3.1.1Health insurance coverage for cannabis use in medical treatments driving market155
TABLE 89GERMANY: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)156
TABLE 90GERMANY: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)156
10.3.2ITALY156
10.3.2.1Increase in demand for cannabis and issuance of import licenses to drive market156
TABLE 91ITALY: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)157
TABLE 92ITALY: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)157
10.3.3DENMARK157
10.3.3.1Huge demand for medical cannabis to drive Danish medical cannabis market157
TABLE 93DENMARK: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)158
TABLE 94DENMARK: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)158
10.3.4NETHERLANDS158
10.3.4.1Strong infrastructure and rise in export of medical cannabis to other countries drive market158
TABLE 95NETHERLANDS: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)159
TABLE 96NETHERLANDS: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)159
10.3.5FRANCE159
10.3.5.1Government providing finance to healthcare systems and refunds provided to patients159
TABLE 97FRANCE: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)160
TABLE 98FRANCE: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)160
10.3.6REST OF EUROPE160
TABLE 99REST OF EUROPE: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)161
TABLE 100REST OF EUROPE: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)162
10.4SOUTH AMERICA162
TABLE 101SOUTH AMERICA: CANNABIS MARKET SIZE, BY COUNTRY, 2018–2021 (USD MILLION)162
TABLE 102SOUTH AMERICA: CANNABIS MARKET SIZE, BY COUNTRY, 2022–2027 (USD MILLION)163
TABLE 103SOUTH AMERICA: CANNABIS MARKET SIZE, BY APPLICATION, 2018–2021 (USD MILLION)163
TABLE 104SOUTH AMERICA: CANNABIS MARKET SIZE, BY APPLICATION, 2022–2027 (USD MILLION)163
TABLE 105SOUTH AMERICA: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)163
TABLE 106SOUTH AMERICA: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)164
TABLE 107SOUTH AMERICA: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2018–2021 (USD MILLION)164
TABLE 108SOUTH AMERICA: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2022–2027 (USD MILLION)164
TABLE 109SOUTH AMERICA: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2018–2021 (TONS)165
TABLE 110SOUTH AMERICA: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2022–2027 (TONS)165
10.4.1CHILE165
10.4.1.1Rise in consumption of cannabis for medical usage driving market165
TABLE 111CHILE: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)166
TABLE 112CHILE: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)166
10.4.2COLOMBIA166
10.4.2.1Increased cannabis license distribution to companies drives market166
TABLE 113COLOMBIA: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)167
TABLE 114COLOMBIA: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)167
10.4.3URUGUAY167
10.4.3.1Fully legalized cannabis industry with eased regulations drives market167
TABLE 115URUGUAY: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)168
TABLE 116URUGUAY: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)168
10.4.4REST OF SOUTH AMERICA168
TABLE 117REST OF SOUTH AMERICA: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)169
TABLE 118REST OF SOUTH AMERICA: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)169
10.5ROW169
TABLE 119ROW: CANNABIS MARKET SIZE, BY COUNTRY, 2018–2021 (USD MILLION)169
TABLE 120ROW: CANNABIS MARKET SIZE, BY COUNTRY, 2022–2027 (USD MILLION)170
TABLE 121ROW: CANNABIS MARKET SIZE, BY APPLICATION, 2018–2021 (USD MILLION)170
TABLE 122ROW: CANNABIS MARKET SIZE, BY APPLICATION, 2022–2027 (USD MILLION)170
TABLE 123ROW: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)170
TABLE 124ROW: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)171
TABLE 125ROW: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2018–2021 (USD MILLION)171
TABLE 126ROW: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2022–2027 (USD MILLION)171
TABLE 127ROW: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2018–2021 (TONS)171
TABLE 128ROW: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2022–2027 (TONS)172
10.5.1ISRAEL172
10.5.1.1Technical innovations and increased exports to drive market172
TABLE 129ISRAEL: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)173
TABLE 130ISRAEL: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)173
10.5.2AUSTRALIA173
10.5.2.1Surge in epilepsy, chronic pain, and cancer patients resulted in market growth173
TABLE 131AUSTRALIA: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)174
TABLE 132AUSTRALIA: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)174
10.5.3OTHERS IN ROW174
TABLE 133OTHERS IN ROW: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)175
TABLE 134OTHERS IN ROW: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)175
11COMPETITIVE LANDSCAPE176
11.1OVERVIEW176
11.2MARKET SHARE ANALYSIS, 2021176
TABLE 135CANNABIS MARKET: DEGREE OF COMPETITION (FRAGMENTED)177
11.3SEGMENTAL REVENUE ANALYSIS OF KEY PLAYERS177
FIGURE 46SEGMENTAL REVENUE ANALYSIS OF KEY PLAYERS IN MARKET, 2017–2021 (USD MILLION)177
11.4KEY PLAYER STRATEGIES178
TABLE 136STRATEGIES ADOPTED BY KEY CANNABIS MANUFACTURERS178
11.5COMPANY EVALUATION QUADRANT (KEY PLAYERS)180
11.5.1STARS181
11.5.2EMERGING LEADERS181
11.5.3PERVASIVE PLAYERS181
11.5.4PARTICIPANTS181
FIGURE 47CANNABIS MARKET: COMPANY EVALUATION QUADRANT, 2021 (KEY PLAYERS)182
11.5.5PRODUCT FOOTPRINT182
TABLE 137COMPANY FOOTPRINT, BY APPLICATION182
TABLE 138COMPANY FOOTPRINT, BY TYPE183
TABLE 139COMPANY FOOTPRINT, BY REGION184
TABLE 140OVERALL COMPANY FOOTPRINT184
11.6CANNABIS MARKET: EVALUATION QUADRANT FOR STARTUPS/SMES, 2021185
11.6.1PROGRESSIVE COMPANIES185
11.6.2STARTING BLOCKS185
11.6.3RESPONSIVE COMPANIES185
11.6.4DYNAMIC COMPANIES185
FIGURE 48CANNABIS MARKET: COMPANY EVALUATION QUADRANT, 2021 (STARTUPS/SMES)186
11.6.5COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES186
TABLE 141CANNABIS MARKET: DETAILED LIST OF KEY STARTUP/SMES186
TABLE 142CANNABIS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES187
11.7PRODUCT LAUNCHES, DEALS, AND OTHER DEVELOPMENTS188
11.7.1PRODUCT LAUNCHES188
TABLE 143CANNABIS: PRODUCT LAUNCHES, 2019–2022188
11.7.2DEALS189
TABLE 144CANNABIS: DEALS, 2019–2022189
11.7.3OTHERS191
TABLE 145CANNABIS: OTHERS, 2019–2022191
12COMPANY PROFILES193
12.1INTRODUCTION193
12.2KEY PLAYER193
(Business overview, Products/Solutions/Services offered, Recent developments, New product launches, Deals, MnM view, Right to win, Strategic choices, and Weaknesses and competitive threats)*
12.2.1CANOPY GROWTH CORPORATION193
TABLE 146CANOPY GROWTH CORPORATION: BUSINESS OVERVIEW193
FIGURE 49CANOPY GROWTH CORPORATION: COMPANY SNAPSHOT194
TABLE 147CANOPY GROWTH CORPORATION: PRODUCTS OFFERED194
TABLE 148CANOPY GROWTH CORPORATION: NEW PRODUCT LAUNCHES196
TABLE 149CANOPY GROWTH CORPORATION: DEALS198
TABLE 150CANOPY GROWTH CORPORATION: OTHERS200
12.2.2CURALEAF202
TABLE 151CURALEAF: BUSINESS OVERVIEW202
FIGURE 50CURALEAF: COMPANY SNAPSHOT202
TABLE 152CURALEAF: PRODUCTS OFFERED203
TABLE 153CURALEAF: NEW PRODUCT LAUNCHES204
TABLE 154CURALEAF: DEALS204
TABLE 155CURALEAF: OTHERS205
12.2.3CRESCO LABS208
TABLE 156CRESCO LABS: BUSINESS OVERVIEW208
FIGURE 51CRESCO LABS: COMPANY SNAPSHOT208
TABLE 157CRESCO LABS: PRODUCTS OFFERED209
TABLE 158CRESCO LABS: NEW PRODUCT LAUNCHES210
TABLE 159CRESCO LABS: DEALS210
TABLE 160CRESCO LABS: OTHERS211
12.2.4GREEN THUMB INDUSTRIES214
TABLE 161GREEN THUMB INDUSTRIES: BUSINESS OVERVIEW214
FIGURE 52GREEN THUMB INDUSTRIES: COMPANY SNAPSHOT214
TABLE 162GREEN THUMB INDUSTRIES: PRODUCTS OFFERED215
TABLE 163GREEN THUMB INDUSTRIES: DEALS215
TABLE 164GREEN THUMB INDUSTRIES: OTHERS216
12.2.5TILRAY218
TABLE 165TILRAY: BUSINESS OVERVIEW218
FIGURE 53TILRAY: COMPANY SNAPSHOT218
TABLE 166TILRAY INC: PRODUCTS OFFERED219
TABLE 167TILRAY: NEW PRODUCT LAUNCHES219
TABLE 168TILRAY: DEALS220
TABLE 169TILRAY: OTHERS220
12.2.6TRULIEVE222
TABLE 170TRULIEVE: BUSINESS OVERVIEW222
FIGURE 54TRULIEVE: COMPANY SNAPSHOT222
TABLE 171TRULIEVE: PRODUCTS OFFERED223
TABLE 172TRULIEVE: DEALS223
TABLE 173TRULIEVE: OTHERS224
12.2.7AURORA CANNABIS INC.227
TABLE 174AURORA CANNABIS INC.: BUSINESS OVERVIEW227
FIGURE 55AURORA CANNABIS INC.: COMPANY SNAPSHOT227
TABLE 175AURORA CANNABIS INC.: PRODUCTS OFFERED228
TABLE 176AURORA CANNABIS INC.: NEW PRODUCT LAUNCHES229
TABLE 177AURORA CANNABIS INC.: DEALS230
TABLE 178AURORA CANNABIS INC.: OTHERS231
12.2.8MEDMEN233
TABLE 179MEDMEN: BUSINESS OVERVIEW233
FIGURE 56MEDMEN: COMPANY SNAPSHOT233
TABLE 180MEDMEN: PRODUCTS OFFERED234
TABLE 181MEDMEN: OTHERS234
12.2.9UNRIVALED BRAND INC.236
TABLE 182UNRIVALED BRAND INC.: BUSINESS OVERVIEW236
FIGURE 57UNRIVALED BRAND INC.: COMPANY SNAPSHOT236
TABLE 183UNRIVALED BRAND INC.: PRODUCTS OFFERED237
TABLE 184UNRIVALED BRAND INC.: DEALS237
TABLE 185UNRIVALED BRAND INC.: OTHERS238
12.2.10ORGANIGRAM HOLDINGS INC.240
TABLE 186ORGANIGRAM HOLDINGS INC.: BUSINESS OVERVIEW240
FIGURE 58ORGANIGRAM HOLDINGS INC.: COMPANY SNAPSHOT240
TABLE 187ORGANIGRAM HOLDINGS INC.: PRODUCTS OFFERED241
TABLE 188ORGANIGRAM HOLDINGS INC.: PRODUCT LAUNCH241
TABLE 189ORGANIGRAM HOLDINGS INC.: DEALS242
TABLE 190ORGANIGRAM HOLDINGS INC.: OTHERS242
12.2.11STENOCARE244
TABLE 191STENOCARE: BUSINESS OVERVIEW244
FIGURE 59STENOCARE: COMPANY SNAPSHOT244
TABLE 192STENOCARE: PRODUCTS OFFERED244
TABLE 193STENOCARE: DEALS245
TABLE 194STENOCARE: OTHERS245
12.2.12VIVO CANNABIS INC.247
TABLE 195VIVO CANNABIS INC.: BUSINESS OVERVIEW247
FIGURE 60VIVO CANNABIS INC.: COMPANY SNAPSHOT247
TABLE 196VIVO CANNABIS INC.: PRODUCTS OFFERED248
TABLE 197VIVO CANNABIS INC.: NEW PRODUCT LAUNCHES249
TABLE 198VIVO CANNABIS INC.: DEALS250
TABLE 199VIVO CANNABIS INC.: OTHERS251
12.2.13TERRASCEND252
TABLE 200TERRASCEND: BUSINESS OVERVIEW252
FIGURE 61TERRASCEND: COMPANY SNAPSHOT252
TABLE 201TERRASCEND: PRODUCTS OFFERED253
TABLE 202TERRASCEND: DEALS254
TABLE 203TERRASCEND: OTHERS255
12.2.14HEXO CORP256
TABLE 204HEXO CORP: BUSINESS OVERVIEW256
FIGURE 62HEXO CORP: COMPANY SNAPSHOT256
TABLE 205HEXO CORP: PRODUCTS OFFERED257
TABLE 206HEXO CORP: NEW PRODUCT LAUNCHES257
TABLE 207HEXO CORP: DEALS258
TABLE 208HEXO CORP: OTHERS259
12.2.15VILLAGE FARMS INTERNATIONAL INC.260
TABLE 209VILLAGE FARMS INTERNATIONAL INC.: BUSINESS OVERVIEW260
FIGURE 63VILLAGE FARMS INTERNATIONAL INC.: COMPANY SNAPSHOT261
TABLE 210VILLAGE FARMS INTERNATIONAL INC.: PRODUCTS OFFERED261
TABLE 211VILLAGE FARMS INTERNATIONAL INC.: OTHERS261
12.2.16VERANO263
TABLE 212VERANO: BUSINESS OVERVIEW263
FIGURE 64VERANO: COMPANY SNAPSHOT263
TABLE 213VERANO: PRODUCTS OFFERED263
TABLE 214VERANO: DEALS264
TABLE 215VERANO: OTHERS266
12.3OTHER PLAYERS (SMES/STARTUPS)269
12.3.1THE CRONOS GROUP269
TABLE 216THE CRONOS GROUP: BUSINESS OVERVIEW269
FIGURE 65THE CRONOS GROUP: COMPANY SNAPSHOT269
TABLE 217THE CRONOS GROUP: PRODUCTS OFFERED270
TABLE 218THE CRONOS GROUP: DEALS271
TABLE 219THE CRONOS GROUP: OTHERS272
12.3.2MEDICAL MARIJUANA, INC.273
TABLE 220MEDICAL MARIJUANA, INC.: BUSINESS OVERVIEW273
FIGURE 66MEDICAL MARIJUANA, INC.: COMPANY SNAPSHOT273
TABLE 221MEDICAL MARIJUANA, INC.: PRODUCTS OFFERED273
TABLE 222MEDICAL MARIJUANA, INC.: NEW PRODUCT LAUNCHES274
TABLE 223MEDICAL MARIJUANA, INC.: DEALS275
TABLE 224MEDICAL MARIJUANA, INC.: OTHERS275
12.3.3ECOFIBRE LIMITED277
TABLE 225ECOFIBRE LIMITED: BUSINESS OVERVIEW277
FIGURE 67ECOFIBRE LIMITED: COMPANY SNAPSHOT277
TABLE 226ECOFIBRE LIMITED: PRODUCTS OFFERED278
TABLE 227ECOFIBRE LIMITED: OTHERS279
12.3.4INDIVA280
TABLE 228INDIVA: BUSINESS OVERVIEW280
FIGURE 68INDIVA: COMPANY SNAPSHOT280
TABLE 229INDIVA: PRODUCTS OFFERED280
TABLE 230INDIVA: NEW PRODUCT LAUNCHES281
TABLE 231INDIVA: DEALS282
TABLE 232INDIVA: OTHERS283
12.3.5TIKUN OLAM-CANNBIT PHARMACEUTICALS LTD.284
TABLE 233TIKUN OLAM-CANNBIT PHARMACEUTICALS LTD.: BUSINESS OVERVIEW284
TABLE 234TIKUN OLAM-CANNBIT PHARMACEUTICALS LTD.: PRODUCTS OFFERED284
12.3.6MARICANN GROUP INC286
TABLE 235MARICANN GROUP INC: BUSINESS OVERVIEW286
TABLE 236MARICANN GROUP INC: PRODUCTS OFFERED286
12.3.7SATIPHARM288
12.3.8CANNABLISS ORGANIC LLC288
12.3.9CONNECTED CANNABIS CO.288
12.3.10JUSTICE C
Related Report
